Abstract:// Xiongzhi Wangpu 1, 2, 3 , Xiao Yang 1, 2, 4 , Jingkun Zhao 1, 2 , Jiaoyang Lu 1, 2 , Shaopei Guan 1, 4 , Jun Lu 1, 2 , Zaklina Kovacevic 3 , Wensheng Liu 1 , Lan Mi 1 , Runsen Jin 1 , Jing Sun 1, 2 , Fei Yue 1, 2 , Junjun Ma 1, 2 , Aiguo Lu 1, 2, 4 , Des R. Richardson 3 , Lishun Wang 5 , Minhua Zheng 1, 2, 4 1 Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China 2 Shanghai Minimally Invasive Surgery Center, Shanghai, 200025, China 3 Molecular Pharmacology and Pathology Program, Department of Pathology and Bosch Institute, University of Sydney, Sydney, New South Wales, 2006, Australia 4 Shanghai Institute of Digestive Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China 5 The Division of Translational Medicine, Minhang Hospital, Fudan University, Shanghai, 201199, China Correspondence to: Minhua Zheng, e-mail: wangpuxz@hotmail.com Lishun Wang, e-mail: lishunwang@fudan.edu.cn Des R. Richardson, e-mail: d.richardson@med.usyd.edu.au Keywords: β-catenin, colorectal cancer, NDRG1, stem cell-like property, tumorigenesis Received: March 18, 2015 Accepted: September 04, 2015 Published: September 18, 2015 ABSTRACT N-myc downstream-regulated gene 1 (NDRG1), has been identified as an important metastasis suppressor for colorectal cancer (CRC). In this study, we investigated: (1) the effects of NDRG1 on CRC stemness and tumorigenesis; (2) the molecular mechanisms involved; and (3) the relationship between NDRG1 expression and colorectal cancer prognosis. Our investigation demonstrated that CRC cells with silenced NDRG1 showed more tumorigenic ability and stem cell-like properties, such as: colony and sphere formation, chemoresistance, cell invasion, high expression of CD44, and tumorigenicity in vivo . Moreover, NDRG1 silencing reduced β-catenin expression on the cell membrane, while increasing its nuclear expression. The anti-tumor activity of NDRG1 was demonstrated to be mediated by preventing β-catenin nuclear translocation, as silencing of this latter molecule could reverse the effects of silencing NDRG1 expression. NDRG1 expression was also demonstrated to be negatively correlated to CRC prognosis. In addition, there was a negative correlation between NDRG1 and nuclear β-catenin and also NDRG1 and CD44 expression in clinical CRC specimens. Taken together, our investigation demonstrates that the anti-metastatic activity of NDRG1 in CRC occurs through the down-regulation of nuclear β-catenin and suggests that NDRG1 is a significant therapeutic target.

NDR1/FBXO11 promotes phosphorylation-mediated ubiquitination of β-catenin to suppress metastasis in prostate cancer

The Metastasis Suppressor, NDRG1, Modulates Β-Catenin Phosphorylation and Nuclear Translocation by Mechanisms Involving FRAT1 and PAK4

Mechanisms of Cytoplasmic β-Catenin Accumulation and Its Involvement in Tumorigenic Activities Mediated by Oncogenic Splicing Variant of the Receptor Originated from Nantes Tyrosine Kinase

E2F1 Renders Prostate Cancer Cell Resistant to ICAM-1 Mediated Antitumor Immunity by NF-κB Modulation.

Knockdown of NDRG1 Promote Epithelial-Mesenchymal Transition of Colorectal Cancer Via NF-κB Signaling.

Downregulation of NDR1 Contributes to Metastasis of Prostate Cancer Cells Via Activating Epithelial‐mesenchymal Transition

N-myc Downstream Regulated Gene 1 Inhibition of Tumor Progression in Caco2 Cells.

Multi-modal mechanisms of the metastasis suppressor, NDRG1: Inhibition of WNT/β-catenin signaling by stabilization of protein kinase Cα

Nuclear receptor NURR1 functions to promote stemness and epithelial-mesenchymal transition in prostate cancer via its targeting of Wnt/β-catenin signaling pathway

The Metastatic Suppressor NDRG1 Inhibits EMT, Migration and Invasion Through Interaction and Promotion of Caveolin-1 Ubiquitylation in Human Colorectal Cancer Cells

The metastasis suppressor, NDRG1, inhibits "stemness" of colorectal cancer via down-regulation of nuclear beta-catenin and CD44

Targeting the Metastasis Suppressor, N-Myc Downstream Regulated Gene-1, with Novel Di-2-Pyridylketone Thiosemicarbazones: Suppression of Tumor Cell Migration and Cell-Collagen Adhesion by Inhibiting Focal Adhesion Kinase/Paxillin Signaling.

NDR2 is Critical for the Osteoclastogenesis by Regulating ULK1-mediated Mitophagy.

The metastasis suppressor, NDRG1, inhibits “stemness” of colorectal cancer <i>via</i> down-regulation of nuclear β-catenin and CD44

Discovery of a small-molecule NDR1 agonist for prostate cancer therapy

NDR1 mediates PD-L1 deubiquitination to promote prostate cancer immune escape via USP10

RON and C-Met Facilitate Metastasis Through the ERK Signaling Pathway in Prostate Cancer Cells.

A Noncanonical E3 Ubiquitin Ligase RNF41-mediated MYO1C Stability Promotes Prostate Cancer Metastasis by Inducing Actin Remodeling

Proteomics Analysis of the Interactome of N-myc Downstream Regulated Gene 1 and Its Interactions with the Androgen Response Program in Prostate Cancer Cells

Targeting Wnt/tenascin C-mediated cross talk between pancreatic cancer cells and stellate cells via activation of the metastasis suppressor NDRG1

The proto-oncogene c-Src and its downstream signaling pathways are inhibited by the metastasis suppressor, NDRG1.